Pressure pain threshold and perceived impact of pain differentially predict short-term and long-term pain reduction following acupuncture in fibromyalgia.

Researchers studying acupuncture for fibromyalgia have discovered that different factors predict whether patients will experience short-term versus long-term pain relief. This study followed 65 fibromyalgia patients who received either real or sham acupuncture treatments twice weekly for 12 weeks, then tracked their progress for an additional 25 weeks.

The researchers measured two things before treatment began: pressure pain threshold (how much pressure triggers pain when applied to the body) and perceived impact of pain (how much pain affects daily life). They found that these measurements predicted different outcomes depending on the treatment type and timing.

For immediate results after the 12-week treatment period, patients with lower pressure pain thresholds responded better to sham acupuncture, while those with higher thresholds had better results with real acupuncture. Patients who reported greater pain impact at the beginning experienced more short-term relief regardless of which treatment they received.

For long-term results measured months after treatment ended, pressure pain threshold no longer predicted outcomes. However, patients who initially reported higher pain impact experienced significantly better long-term pain relief with real acupuncture compared to sham treatment.

What this means for patients: If fibromyalgia significantly impacts your daily life, real acupuncture may provide lasting pain relief that continues long after treatment ends. These findings suggest that your personal pain experience—not just physical measurements—is an important predictor of acupuncture's long-term effectiveness. When considering acupuncture for fibromyalgia, seek treatment from a licensed acupuncturist experienced in treating chronic pain conditions.

This secondary analysis of a randomized, sham-controlled trial (n=65; verum=36, sham=29) examined predictors of acupuncture analgesia in fibromyalgia patients receiving 18 treatments over 12 weeks with 37-week follow-up. Baseline pressure pain threshold (PPT) and pain interference were assessed as predictors of residualized pain intensity change.

Short-term outcomes showed differential treatment response based on PPT: lower baseline PPT predicted greater sham response, while higher PPT predicted superior verum response (B=-13.43, P=0.001). Greater baseline pain interference predicted short-term analgesia regardless of treatment allocation.

Long-term analysis revealed PPT was not predictive of sustained analgesia (B=-1.71, P=0.66). However, baseline pain interference significantly predicted differential long-term response, with higher pain interference associated with superior sustained analgesia in the verum group compared to sham (B=-11.37, P=0.004).

Clinical implications: Self-reported pain interference measures may be more valuable than objective PPT assessments for identifying fibromyalgia patients likely to achieve sustained benefit from acupuncture treatment.